- •Preface and Acknowledgments
- •Contents
- •Contributors
- •1: Embryology for Urologists
- •Introduction
- •Renal Development
- •Pronephros
- •Mesonephros
- •Metanephros
- •Development of the Collecting System
- •Critical Steps in Further Development
- •Anomalies of the Kidney
- •Renal Agenesis
- •Renal Aplasia
- •Renal Hypoplasia
- •Renal Ectopia
- •Renal Fusion
- •Ureteral Development
- •Anomalies of Origin
- •Anomalies of Number
- •Incomplete Ureteral Duplication
- •Complete Ureteral Duplication
- •Ureteral Ectopia
- •Embryology of Ectopia
- •Clinical Correlation
- •Location of Ectopic Ureteral Orifices – Male (in Descending Order According to Incidence)
- •Symptoms
- •Ureteroceles
- •Congenital Ureteral Obstruction
- •Pipestem Ureter
- •Megaureter-Megacystis Syndrome
- •Prune Belly Syndrome
- •Vascular Ureteral Obstructions
- •Division of the Urogenital Sinus
- •Bladder Development
- •Urachal Anomalies
- •Cloacal Duct Anomalies
- •Other Bladder Anomalies
- •Bladder Diverticula
- •Bladder Extrophy
- •Gonadal Development
- •Testicular Differentiation
- •Ovarian Differentiation
- •Gonadal Anomalies
- •Genital Duct System
- •Disorders of Testicular Function
- •Female Ductal Development
- •Prostatic Urethral Valves
- •Gonadal Duct Anomalies
- •External Genital Development
- •Male External Genital Development
- •Female External Genital Development
- •Anomalies of the External Genitalia
- •References
- •2: Gross and Laparoscopic Anatomy of the Upper Urinary Tract and Retroperitoneum
- •Overview
- •The Kidneys
- •The Renal Vasculature
- •The Renal Collecting System
- •The Ureters
- •Retroperitoneal Lymphatics
- •Retroperitoneal Nerves
- •The Adrenal Glands
- •References
- •3: Gross and Laparoscopic Anatomy of the Lower Urinary Tract and Pelvis
- •Introduction
- •Female Pelvis
- •Male Pelvis
- •Pelvic Floor
- •Urinary Bladder
- •Urethra
- •Male Urethra
- •Female Urethra
- •Sphincter Mechanisms
- •The Bladder Neck Component
- •The Urethral Wall Component
- •The External Urethral Sphincter
- •Summary
- •References
- •4: Anatomy of the Male Reproductive System
- •Testis and Scrotum
- •Spermatogenesis
- •Hormonal Regulation of Spermatogenesis
- •Genetic Regulation of Spermatogenesis
- •Epididymis and Ductus Deferens
- •Accessory Sex Glands
- •Prostate
- •Seminal Vesicles
- •Bulbourethral Glands
- •Penis
- •Erection and Ejaculation
- •References
- •5: Imaging of the Upper Tracts
- •Anatomy of the Upper Tracts and Introduction to Imaging Modalities
- •Introduction
- •Renal Upper Tract Basic Anatomy
- •Modalities Used for Imaging the Upper Tracts
- •Ultrasound
- •Radiation Issues
- •Contrast Issues
- •Renal and Upper Tract Tumors
- •Benign Renal Tumors
- •Transitional Cell Carcinoma
- •Renal Mass Biopsy
- •Renal Stone Disease
- •Ultrasound
- •Plain Radiographs and IVU
- •Renal Cystic Disease
- •Benign Renal Cysts
- •Hereditary Renal Cystic Disease
- •Complex Renal Cysts
- •Renal Trauma
- •References
- •Introduction
- •Pathophysiology
- •Susceptibility and Resistance
- •Epidemiological Breakpoints
- •Clinical Breakpoints
- •Pharmacodynamic Parameters
- •Pharmacokinetic Parameters
- •Fosfomycin
- •Nitrofurantoin
- •Pivmecillinam
- •b-Lactam-Antibiotics
- •Penicillins
- •Cephalosporins
- •Carbapenems
- •Aminoglycosides
- •Fluoroquinolones
- •Trimethoprim, Cotrimoxazole
- •Glycopeptides
- •Linezolid
- •Conclusion
- •References
- •7: An Overview of Renal Physiology
- •Introduction
- •Body Fluid Compartments
- •Regulation of Potassium Balance
- •Regulation of Acid–Base Balance
- •Diuretics
- •Suggested Reading
- •8: Ureteral Physiology and Pharmacology
- •Ureteral Anatomy
- •Modulation of Peristalsis
- •Ureteral Pharmacology
- •Conclusion
- •References
- •Introduction
- •Afferent Signaling Pathways
- •Efferent Signaling
- •Parasympathetic Nerves
- •Sympathetic Nerves
- •Vesico-Spinal-Vesical Micturition Reflex
- •Peripheral Targets
- •Afferent Signaling Mechanisms
- •Urothelium
- •Myocytes
- •Cholinergic Receptors
- •Muscarinic Receptors
- •Nicotinic Receptors
- •Adrenergic Receptors (ARs)
- •a-Adrenoceptors
- •b-Adrenoceptors
- •Transient Receptor Potential (TRP) Receptors
- •Phosphodiesterases (PDEs)
- •CNS Targets
- •Opioid Receptors
- •Serotonin (5-HT) Mechanisms
- •g-Amino Butyric Acid (GABA) Mechanisms
- •Gabapentin
- •Neurokinin and Neurokinin Receptors
- •Summary
- •References
- •10: Pharmacology of Sexual Function
- •Introduction
- •Sexual Desire/Arousal
- •Endocrinology
- •Steroids in the Male
- •Steroids in the Female
- •Neurohormones
- •Neurotransmitters
- •Dopamine
- •Serotonin
- •Pharmacological Strategies
- •CNS Drugs
- •Enzyme-inducing Antiepileptic Drugs
- •Erectile Function
- •Ejaculatory Function
- •Premature Ejaculation
- •Abnormal Ejaculation
- •Conclusions
- •References
- •Epidemiology
- •Calcium-Based Urolithiasis
- •Uric Acid Urolithiasis
- •Infectious Urolithiasis
- •Cystine-Based Urolithiasis
- •Aims
- •Who Deserves Metabolic Evaluation?
- •Metabolic Workup for Stone Producers
- •Medical History and Physical Examination
- •Stone Analysis
- •Serum Chemistry
- •Urine Evaluation
- •Urine Cultures
- •Urinalysis
- •Twenty-Four Hour Urine Collections
- •Radiologic Imaging
- •Medical Management
- •Conservative Management
- •Increased Fluid Intake
- •Citrus Juices
- •Dietary Restrictions
- •Restricted Oxalate Diet
- •Conservative Measures
- •Selective Medical Therapy
- •Absorptive Hypercalciuria
- •Thiazide
- •Orthophosphate
- •Renal Hypercalciuria
- •Primary Hyperparathyroidism
- •Hyperuricosuric Calcium Oxalate Nephrolithiasis
- •Enteric Hyperoxaluria
- •Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Distal Renal Tubular Acidosis
- •Chronic Diarrheal States
- •Thiazide-Induced Hypocitraturia
- •Idiopathic Hypocitraturic Calcium Oxalate Nephrolithiasis
- •Hypomagnesiuric Calcium Nephrolithiasis
- •Gouty Diathesis
- •Cystinuria
- •Infection Lithiasis
- •Summary
- •References
- •12: Molecular Biology for Urologists
- •Introduction
- •Inherited Changes in Cancer Cells
- •VEGR and Cell Signaling
- •Targeting mTOR
- •Conclusion
- •References
- •13: Chemotherapeutic Agents for Urologic Oncology
- •Introduction
- •Bladder Cancer
- •Muscle Invasive Bladder Cancer
- •Metastatic Bladder Cancer
- •Conclusion
- •Prostate Cancer
- •Other Chemotherapeutic Drugs or Combinations for Treating HRPC
- •Conclusion
- •Renal Cell Carcinoma
- •Chemotherapy
- •Immunotherapy
- •Angiogenesis Inhibitor Drugs
- •Conclusion
- •Testicular Cancer
- •Stage I Seminoma
- •Stage I non-seminomatous Germ Cell Tumours (NSGCT)
- •Metastatic Germ Cell Tumours
- •Low-Volume Metastatic Disease (Stage II A/B)
- •Advanced Metastatic Disease
- •Salvage Chemotherapy for Relapsed or Refractory Disease
- •Conclusion
- •Penile Cancer
- •Side Effects of Chemotherapy
- •Conclusion
- •References
- •14: Tumor and Transplant Immunology
- •Antibodies
- •Cytotoxic and T-helper Cells
- •Immunosuppression
- •Induction Therapy
- •Maintenance Therapy
- •Rejection
- •Posttransplant Lymphoproliferative Disease
- •Summary
- •References
- •15: Pathophysiology of Renal Obstruction
- •Causes of Renal Obstruction
- •Effects on Prenatal Development
- •Prenatal Hydronephrosis
- •Spectrum of Renal Abnormalities
- •Renal Functional Changes
- •Renal Growth/Counterbalance
- •Vascular Changes
- •Inflammatory Mediators
- •Glomerular Development Changes
- •Mechanical Stretch of Renal Tubules
- •Unilateral Versus Bilateral
- •Limitations of Animal Models
- •Future Research
- •Issues in Patient Management
- •Diagnostic Imaging
- •Ultrasound
- •Intravenous Urography
- •Antegrade Urography and the Whitaker Test
- •Nuclear Renography
- •Computed Tomography
- •Magnetic Resonance Urography
- •Hypertension
- •Postobstructive Diuresis
- •References
- •Introduction
- •The Normal Lower Urinary Tract
- •Anatomy
- •Storage Function
- •Voiding Function
- •Neural Control
- •Symptoms
- •Flow Rate and Post-void Residual
- •Voiding Cystometry
- •Male
- •Female
- •Neurourology
- •Conclusions
- •References
- •17: Urologic Endocrinology
- •The Testis
- •Normal Androgen Metabolism
- •Epidemiological Aspects
- •Prostate
- •Brain
- •Muscle Mass and Adipose Tissue
- •Bones
- •Ematopoiesis
- •Metabolism
- •Cardiovascular System
- •Clinical Assessment
- •Biochemical Assessment
- •Treatment Modalities
- •Oral Preparations
- •Parenteral Preparations
- •Transdermal Preparations
- •Side Effects and Treatment Monitoring
- •Body Composition
- •Cognitive Decline
- •Bone Metabolism
- •The Kidneys
- •Endocrine Functions of the Kidney
- •Erythropoietin
- •Calcitriol
- •Renin
- •Paraneoplastic Syndromes
- •Hypercalcemia
- •Hypertension
- •Polycythemia
- •Other Endocrine Abnormalities
- •References
- •General Physiology
- •Prostate Innervation
- •Summary
- •References
- •Wound Healing
- •Inflammation
- •Proliferation
- •Remodeling
- •Principles of Plastic Surgery
- •Tissue Characteristics
- •Grafts
- •Flap
- •References
- •Lower Urinary Tract Symptoms
- •Storage Phase
- •Voiding Phase
- •Return to Storage Phase
- •Urodynamic Parameters
- •Urodynamic Techniques
- •Volume Voided Charts
- •Pad Testing
- •Typical Test Schedule
- •Uroflowmetry
- •Post Voiding Residual
- •Further Diagnostic Evaluation of Patients
- •Cystometry with or Without Video
- •Cystometry
- •Videocystometrography (Cystometry + Cystourethrography)
- •Cystometric Findings
- •Comment:
- •Measurements During the Storage Phase:
- •Measurements During the Voiding Phase:
- •Abnormal Function
- •Disorders of Sensation
- •Causes of Hypersensitive Bladder Sensation
- •Causes of Hyposensitive Bladder Sensation
- •Disorders of Detrusor Motor Function
- •Bladder Outflow Tract Dysfunction
- •Detrusor–Urethral Dyssynergia
- •Detrusor–Bladder Neck Dyssynergia
- •Detrusor–Sphincter Dyssynergia
- •Complex Urodynamic Investigation
- •Urethral Pressure Measurement
- •Technique
- •Neurophysiological Evaluation
- •Conclusion
- •References
- •Endoscopy
- •Cystourethroscopy
- •Ureteroscopy and Ureteropyeloscopy
- •Nephroscopy
- •Virtual Reality Simulators
- •Lasers
- •Clinical Application of Lasers
- •Condylomata Acuminata
- •Urolithiasis
- •Benign Prostatic Hyperplasia
- •Ureteral and Urethral Strictures
- •Conclusion
- •References
- •Introduction
- •The Prostatitis Syndromes
- •The Scope of the Problem
- •Category III CP/CPPS
- •The Goal of Treatment
- •Conservative Management
- •Drug Therapy
- •Antibiotics
- •Anti-inflammatories
- •Alpha blockers
- •Hormone Therapies
- •Phytotherapies
- •Analgesics, muscle relaxants and neuromodulators
- •Surgery
- •A Practical Management Plan
- •References
- •Orchitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment of Infectious Orchitis
- •Epididymitis
- •Definition and Etiology
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation of Epididymitis
- •Treatment of Acute Epididymitis
- •Treatment of Chronic Epididymitis
- •Treatment of Spermatic Cord Torsion
- •Fournier’s Gangrene
- •Definition and Etiology
- •Risk Factors
- •Clinical Signs and Symptoms
- •Diagnostic Evaluation
- •Treatment
- •References
- •Fungal Infections
- •Candidiasis
- •Aspergillosis
- •Cryptococcosis
- •Blastomycosis
- •Coccidioidomycosis
- •Histoplasmosis
- •Radiographic Findings
- •Treatment
- •Tuberculosis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Schistosomiasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Filariasis
- •Clinical Manifestations
- •Diagnosis
- •Treatment
- •Onchocerciasis
- •References
- •25: Sexually Transmitted Infections
- •Introduction
- •STIs Associated with Genital Ulcers
- •Herpes Simplex Virus
- •Diagnosis
- •Treatment
- •Chancroid
- •Diagnosis
- •Treatment
- •Syphilis
- •Diagnosis
- •Treatment
- •Lymphogranuloma Venereum
- •Diagnosis
- •Treatment
- •Chlamydia
- •Diagnosis
- •Treatment
- •Gonorrhea
- •Diagnosis
- •Treatment
- •Trichomoniasis
- •Diagnosis
- •Treatment
- •Human Papilloma Virus
- •Diagnosis
- •Treatment
- •Scabies
- •Diagnosis
- •Treatment
- •References
- •26: Hematuria: Evaluation and Management
- •Introduction
- •Classification of Hematuria
- •Macroscopic Hematuria
- •Microscopic Hematuria
- •Dipstick Hematuria
- •Pseudohematuria
- •Factitious Hematuria
- •Menstruation
- •Aetiology
- •Malignancy
- •Urinary Calculi
- •Infection and Inflammation
- •Benign Prostatic Hyperplasia
- •Trauma
- •Drugs
- •Nephrological Causes
- •Assessment
- •History
- •Examination
- •Investigations
- •Dipstick Urinalysis
- •Cytology
- •Molecular Tests
- •Blood Tests
- •Flexible Cystoscopy
- •Upper Urinary Tract Evaluation
- •Renal USS
- •KUB Abdominal X-Ray
- •Intravenous Urography (IVU)
- •Computed Tomography (CT)
- •Retrograde Urogram Studies
- •Magnetic Resonance Imaging (MRI)
- •Additional Tests and Renal Biopsy
- •Intractable Hematuria
- •Loin Pain Hematuria Syndrome
- •References
- •27: Benign Prostatic Hyperplasia (BPH)
- •Historical Background
- •Pathophysiology
- •Patient Assessment
- •Treatment of BPH
- •Watchful Waiting
- •Drug Therapy
- •Interventional Therapies
- •Conclusions
- •References
- •28: Practical Guidelines for the Treatment of Erectile Dysfunction and Peyronie´s Disease
- •Erectile Dysfunction
- •Introduction
- •Diagnosis
- •Basic Evaluation
- •Cardiovascular System and Sexual Activity
- •Optional Tests
- •Treatment
- •Medical Treatment
- •Oral Agents
- •Phosphodiesterase Type 5 (PDE 5) Inhibitors
- •Nonresponders to PDE5 Inhibitors
- •Apomorphine SL
- •Yohimbine
- •Intracavernosal and Intraurethral Therapy
- •Intracavernosal Injection (ICI) Therapy
- •Intraurethral Therapy
- •Vacuum Constriction Devices
- •Surgical Therapy
- •Conclusion
- •Peyronie´s Disease (PD)
- •Introduction
- •Oral Drug Therapy
- •Intralesional Drug Therapy
- •Iontophoresis
- •Radiation Therapy
- •Surgical Therapy
- •References
- •29: Premature Ejaculation
- •Introduction
- •Epidemiology
- •Defining Premature Ejaculation
- •Voluntary Control
- •Sexual Satisfaction
- •Distress
- •Psychosexual Counseling
- •Pharmacological Treatment
- •On-Demand Treatment with Tramadol
- •Topical Anesthetics
- •Phosphodiesterase Inhibitors
- •Surgery
- •Conclusion
- •References
- •30: The Role of Interventional Management for Urinary Tract Calculi
- •Contraindications to ESWL
- •Complications of ESWL
- •PCNL Access
- •Instrumentation for PCNL
- •Nephrostomy Drains Post PCNL
- •Contraindications to PCNL
- •Complications of PCNL
- •Semirigid Ureteroscopy
- •Flexible Ureteroscopy
- •Electrohydraulic Lithotripsy (EHL)
- •Ultrasound
- •Ballistic Lithotripsy
- •Laser Lithotripsy
- •Ureteric Stents
- •Staghorn Calculi
- •Lower Pole Stones
- •Horseshoe Kidneys and Stones
- •Calyceal Diverticula Stones
- •Stones and PUJ Obstruction
- •Treatment of Ureteric Colic
- •Medical Expulsive Therapy (MET)
- •Intervention for Ureteric Stones
- •Stones in Pregnancy
- •Morbid Obesity
- •References
- •Anatomy and Function
- •Pathophysiology
- •Management
- •Optical Urethrotomy/Dilatation
- •Urethral Stents
- •Preoperative Assessment
- •Urethroplasty
- •Anastomotic Urethroplasty
- •Substitution Urethroplasty
- •Grafts Versus Flaps
- •Oral Mucosal Grafts
- •Tissue Engineering
- •Graft Position
- •Conclusion
- •References
- •32: Urinary Incontinence
- •Epidemiology and Risk Factors
- •Pathophysiology
- •Urge Incontinence
- •Conservative Treatments
- •Pharmacotherapy
- •Invasive/ Surgical Therapies
- •Stress Urinary Incontinence
- •Male SUI Therapies
- •Female SUI Therapies
- •Mixed Urinary Incontinence
- •Conclusions
- •References
- •33: Neurogenic Bladder
- •Introduction
- •Examination and Diagnostic Tests
- •History and Physical Examination
- •Imaging
- •Urodynamics (UDS)
- •Evoked Potentials
- •Classifications
- •Somatic Pathways
- •Brain Lesions
- •Cerebrovascular Accident (CVA)
- •Parkinson’s Disease (PD)
- •Multiple Sclerosis
- •Huntington’s Disease
- •Dementias
- •Normal Pressure Hydrocephalus (NPH)
- •Tumors
- •Psychiatric Disorders
- •Spinal Lesions and Pathology
- •Intervertebral Disk Prolapse
- •Spinal Cord Injury (SCI)
- •Transverse Myelitis
- •Peripheral Neuropathies
- •Metabolic Neuropathies
- •Pelvic Surgery
- •Treatment
- •Summary
- •References
- •34: Pelvic Prolapse
- •Introduction
- •Epidemiology
- •Anatomy and Pathophysiology
- •Evaluation and Diagnosis
- •Outcome Measures
- •Imaging
- •Urodynamics
- •Indications for Management
- •Biosynthetics
- •Surgical Management
- •Anterior Compartment Repair
- •Uterine/Apical Prolapse
- •Enterocele Repair
- •Conclusion
- •References
- •35: Urinary Tract Fistula
- •Introduction
- •Urogynecologic Fistula
- •Vesicovaginal Fistula
- •Etiology and Risk Factors
- •Clinical Factors
- •Evaluation and Diagnosis
- •Pelvic Examination
- •Cystoscopy
- •Imaging
- •Treatment
- •Conservative Management
- •Surgical Management
- •Urethrovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Ureterovaginal Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Vesicouterine Fistula
- •Etiology and Presentation
- •Diagnosis and Management
- •Uro-Enteric Fistula
- •Vesicoenteric Fistula
- •Pyeloenteric Fistula
- •Urethrorectal Fistula
- •References
- •36: Urologic Trauma
- •Introduction
- •Kidney
- •Expectant Management
- •Endovascular Therapy
- •Operative Intervention
- •Operative Management: Follow-up
- •Reno-Vascular Injuries
- •Pediatric Renal Injuries
- •Adrenal
- •Ureter
- •Diagnosis
- •Treatment
- •Delayed Diagnosis
- •Bladder and Posterior Urethra
- •Bladder Injuries: Initial Management
- •Bladder Injuries: Formal Repair
- •Anterior Urethral Trauma
- •Fractured Penis
- •Penile Amputation
- •Scrotal and Testicular Trauma
- •Imaging
- •CT-IVP (CT with Delayed Images)
- •Technique
- •Cystogram
- •Technique
- •Retrograde Urethrogram (RUG)
- •Technique
- •Retrograde Pyelogram (RPG)
- •Technique
- •One-Shot IVP
- •Technique
- •References
- •37: Bladder Cancer
- •Who Should Be Investigated?
- •Epidemiology
- •Risk Factors
- •Role of Screening
- •Signs and Symptoms
- •Imaging
- •Cystoscopy
- •Urine Tests
- •PDD-Assisted TUR
- •Pathology
- •NMIBC and Risk Groups
- •Intravesical Chemotherapy
- •Intravesical Immunotherapy
- •Immediate Cystectomy and CIS
- •Radical Cystectomy with Pelvic Lymph Node Dissection
- •sexual function-preserving techniques
- •Bladder-Preservation Treatments
- •Neoadjuvant Chemotherapy
- •Adjuvant Chemotherapy
- •Preoperative Radiotherapy
- •Follow-up After TUR in NMIBC
- •References
- •38: Prostate Cancer
- •Introduction
- •Epidemiology
- •Race
- •Geographic Variation
- •Risk Factors and Prevention
- •Family History
- •Diet and Lifestyle
- •Prevention
- •Screening and Diagnosis
- •Current Screening Recommendations
- •Biopsy
- •Pathology
- •Prognosis
- •Treatment of Prostate Cancer
- •Treatment for Localized Prostate Cancer (T1, T2)
- •Radical Prostatectomy
- •EBRT
- •IMRT
- •Brachytherapy
- •Treatment for Locally Advanced Prostate Cancer (T3, T4)
- •EBRT with ADT
- •Radical Prostatectomy
- •Androgen-Deprivation Therapy
- •Summary
- •References
- •39: The Management of Testis Cancer
- •Presentation and Diagnosis
- •Serum Tumor Markers
- •Primary Surgery
- •Testis Preserving Surgery
- •Risk Stratification
- •Surveillance Versus Primary RPLND
- •Primary RPLND
- •Adjuvant Treatment for High Risk
- •Clinical Stage 1 Seminoma
- •Risk-Stratified Adjuvant Treatment
- •Adjuvant Radiotherapy
- •Adjuvant Low Dose Chemotherapy
- •Primary Combination Chemotherapy
- •Late Toxicity
- •Salvage Strategies
- •Conclusion
- •References
- •Index
16
Pathophysiology of Lower Urinary Tract
Obstruction
Marcus J. Drake and Ahmed M. Shaban
Introduction
Lower urinary tract obstruction signifies impedance of urine expulsion. It can give rise to symptoms, though some people who appear to have outlet obstruction do not complain of any symptomatic problem. Classically associated with benign prostate enlargement in men,obstruction is being increasingly recognized in women, and there is ongoing debate on how to diagnose the problem.In particular,symptoms similar to those of obstruction can derive from reduced expulsive ability associated with impaired bladder contractility, and the latter complicates the objective evaluation of outlet function. Mechanisms of obstruction can be either anatomical or functional, and the fundamental role of the central nervous system in regulating the phases of the micturition cycle and ensuring the synergic activity of the lower urinary tract means outlet obstruction in neurological disease is an important consideration.
The Normal Lower Urinary Tract
Anatomy
The lower urinary tract comprises the bladder and the bladder outlet. The bladder serves as the urine reservoir for storage and the expulsive organ for voiding. The muscle of the bladder wall is the detrusor, and the bladder lumen is
lined by functionally active urothelium, subjacent to which is a dense plexus of nerves and interstitial cells.
The bladder outlet comprises the urethra and urethral sphincters; it is anatomically complex and is different for men and women. In men, the urethra is of greater length and is subdivided into membranous, bulbar, and pendulous parts. At the start of the male urethra, the bladder neck serves as a genital sphincter, constricting at the time of seminal emission and ejaculation to ensure semen is propelled without passing retrogradely into the bladder. Just distal to the male bladder neck is the prostate, a secretory organ, which houses the ends of the ejaculatory ducts. The urethral sphincters are located just distal to the apex of the prostate, at the level of the pelvic floor. In women, the urethra is comparatively short (2–3 cm), and the bladder neck is anatomically poorly defined, probably serving no major functional role for continence. The urethral sphincters lie at the level of the pelvic floor, approximately at the midpoint of the urethra.
For both genders, the urethral sphincter comprises smooth muscle (leiosphincter), which provides the background continuous contraction, and an external skeletal muscle component (rhabdosphincter), for voluntary and reflex increases in urethral closure.The muscular component is distributed asymmetrically.1 In women, supportive anchoring to the pelvic floor and ligaments is a key aspect for normal function,2 along with a firm “back-plate0065” for urethral compression.3,4
C.R. Chapple and W.D. Steers (eds.), Practical Urology: Essential Principles and Practice, |
207 |
DOI: 10.1007/978-1-84882-034-0_16, © Springer-Verlag London Limited 2011 |
|
|
|
208 |
|
|
|
|
|
|
|
Practical Urology: EssEntial PrinciPlEs and PracticE |
|
Storage Function |
throughout the muscle, which binds to muscar- |
||
|
|
inic receptors.13 In addition, intrinsic cellular |
|
Urinary storage is dependent on relaxation of |
structures may provide the sustained contr- |
||
the bladder to maximize reservoir capacity, |
action that maintains voiding until bladder |
||
combined with simultaneous closure of the out- |
emptying is complete.14 Synchronously, outlet |
||
let. The detrusor has some specific properties |
relaxation permits the easy flow of urine along |
||
that allow it to elongate substantially without |
the urethra, with the peripheral nerves crucial |
||
generating force during storage5; in addition, |
in ensuring active relaxation of the smooth |
||
the muscle is inhibited by the sympathetic ner- |
muscle components of the outlet.15,16 |
||
vous system. |
Voiding can be evaluated urodynamically, by |
||
The nature of the sphincter activity can be |
simultaneously recording pressure within the |
||
demonstrated by urethral pressure profilometry, |
bladder, the abdomen, and the urinary flow rate. |
||
in which a catheter is drawn along the urethra, |
Subtraction of abdominal pressure allows esti- |
||
while measuring the pressure needed to keep |
mation of the component of the bladder pres- |
||
continuous perfusion of saline through holes in |
sure that is due to active detrusor contraction. |
||
the side of the catheter.6 This technique provides |
In men, this detrusor pressure shows a clear |
||
an indication of tonic background contraction, |
increase at the time of voiding (Fig. 16.1); the |
||
additional superimposed voluntary contraction |
pressure rise is less clearly apparent in women, |
||
and the tone of the non-sphincteric parts of the |
because the overall lower outlet resistance |
||
urethra. |
results in pressure dissipation (Fig. 16.2). |
||
In men, circular constriction by sphincter |
|
||
activity is crucial for continence. In addition, the |
Neural Control |
||
bladder neck is kept closed by sympathetic |
|||
innervation, acting through alpha-1 adrenergic |
The central nervous system (CNS) is responsible |
||
receptors.7 Furthermore, tonic urethral contrac- |
|||
tion, sustained by intrinsic urethral cellular |
for regulating lower urinary tract function, |
||
imposing several crucial properties which define |
|||
mechanisms,8 means that the greater length of |
|||
the male urethra renders men less prone to uri- |
normal function; |
||
|
|||
nary incontinence. Finally, the prostate provides |
1. During urine storage, activity in Onuf’s nuc- |
||
both active (contractile) and passive (elastic) |
|||
leus in the ventral horn of the sacral part of |
|||
contributions to outlet resistance, which are |
|||
the spinal cord maintains outlet closure. |
|||
affected by ongoing prostate growth.9 None- |
|||
theless, while the bladder neck, prostate, and |
2. During urine storage, the sympathetic neu- |
||
rones in the intermediolateral horn of the |
|||
urethra provide some additional outlet closure, |
|||
their removal by standard prostate surgery does |
thoracolumbar spinal cord inhibit detrusor |
||
not normally result in incontinence. |
activity and maintain bladder neck closure. |
||
In women, sphincteric contraction serves |
3. The pontine part of the brainstem (“pontine |
||
both to elongate the urethra10 and to “kink” it.11 |
micturition center”) and parts of the mid- |
||
Additionally, the closure of the urethra is main- |
|||
brain ensure the synergic function of the |
|||
tained by coaptation of the lining urothelium. |
|||
bladder outlet and detrusor, such that only |
|||
Overall, continence is maintained by numerous |
|||
one element is actively contracting at any |
|||
factors.12 |
|||
|
|
given moment. During voiding, the PMC |
|
|
|
actively relaxes the outlet by inhibition of |
|
Voiding Function |
Onuf’s nucleus, while the parasympathetic |
||
Voiding represents a reversal of the bladder and |
neurones in the intermediolateral horn of the |
||
sacral spinal cord are activated to drive detru- |
|||
outlet roles from that during storage, with global |
|||
sor contraction. |
|||
contraction of the detrusor muscle providing |
|||
4. The frontal cortex allows volitional control, |
|||
expulsive pressure, and synchronous outlet |
|||
so an individual has executive control on |
|||
relaxation to permit flow. Detrusor contraction |
|||
timing of micturition, which is thereby pos- |
|||
is achieved by widespread release of acetylcho- |
|||
line from the parasympathetic nerves ramifying |
sible regardless of extent of bladder filling. |
209
PathoPhysiology of lowEr Urinary tract obstrUction
Figure 16.1. Male voiding cystometrogram; simultaneous pressure recordings have been made from a catheter in the rectum (red line) as a measure of abdominal pressure, and another catheter in the bladder (blue line). since the bladder is an intraabdominal organ, abdominal pressure change is visible in the bladder; subtracting the abdominal pressure allows the investigator to see when the bladder itself is contracting, which is plotted as the “subtracted detrusor pressure” (green line). flow rate is shown in black.the top panel shows a normal male; at the time
5.Additional CNS functions include sensory awareness of bladder filling, emotional aspects, and coordination with other vegetative functions such as bowel opening and blood pressure
100 Pves
39
177 Ÿ
0 cm H20
100 Pabd
26
179 Ÿ
0 cm H20
100 Pdet
13
149 Ÿ
0 cm H20
25 Flow
0
15 Ÿ
0 mL/s
600 VH20
140 Pves
48
593 Ÿ
0 cm H20
100 Pabd
31
142 Ÿ
0 cm H20
140 Pdet
17
563 Ÿ
0 cm H20
25 Flow
0
4Ÿ
0 mL/s
600 VH20
of the maximum flow of 14.6 ml/s, the subtracted detrusor pressure is 43.4. from the equation PdetQmax − 2Qmax, this gives a booi of 14.2; anything below 20 is defined as not obstructed. in the lower panel, the study is of a man with bladder outlet obstruction.
PdetQmax is 122, and Qmax is 2.5, giving a booi of 117; anything above 40 is taken as unequivocally obstructed. this man is also
straining in an attempt to improve his flow rate, shown by the simultaneous intermittent increases in both abdominal and bladder pressure during the time of urine flow.
Diagnosing Bladder Outlet
Obstruction
Symptoms
The complexity of CNS control means that lower urinary tract dysfunction is a common consequence of clinical neurological disease.
Bladder outlet obstruction (BOO) represents a problem whereby some impedance, whether functional or anatomical, prevents the free flow
210
Practical Urology: EssEntial PrinciPlEs and PracticE
Figure 16.2. female voiding cystometrogram; both women in this figure have previously had stress incontinence surgery. in the top trace, a lady who previously had had a colposuspension; the urine flow rate is fairly good (Qmax 12.2 ml/s), and associated increase in detrusor pressure to achieve this is very small (which
of urine from the bladder. This may be asymptomatic if the detrusor contractility increases the pressure of expulsion. Nonetheless, in many patients there will be lower urinary tract symptoms (LUTS),including“voiding symptoms”experienced during voiding, and post-micturition symptoms immediately afterward (Table 16.1). A combination of BOO and reduced contractility can result in a post-void residual and chronic urinary retention. Ultimately, complete inability to void can arise from severe BOO, culminating as acute urinary retention – a painful bladder distension which presents as an emergency to
is common in women). in the lower panel, from a lady with outlet obstruction after tVt, there is a greater increase in detrusor pressure,flow fails to start for some time,flow is intermittent,and the patient is straining. there was a significant post-void residual in the tVt patient, and no residual in the colposuspension patient.
relieve the obstruction. Any of the symptoms listed in Table 16.1 suggests the possibility of BOO. However, very similar symptoms arise in people with reduced bladder contractility; thus, symptoms alone are inadequate for diagnosing BOO.19 A complicating factor is the high prevalence of storage phase symptoms in people with BOO. It is unclear whether BOO gives rise to secondary bladder changes predisposing to storage LUTS. Certainly, BOO in the experimental setting leads to detrusor hypertrophy and abnormal detrusor contractions during bladder filling.20 However, in the clinical setting, the relationship